Pace Corp., Boehringer Mannheim GmbH deal

Boehringer exercised its option to further collaborate in the development of PACL's cardiac diagnostic tests based on Glycogen Phosphorylase BB (see BioCentury Oct. 16). PACL will receive royalties, ...